Iliad Gives up Pursuit for Acquisition of T-Mobile

French telecom major Iliad has given up its pursuit for the purchase of T-Mobile as it gears up to enter the American wireless industry. Initially, Iliad was aggressively trying to purchase T-Mobile from Deutsche Telekom (the parent company). An October deadline had been laid down by the management of Iliad to decide on whether or not its initial offer of US$15 billion would be scaled up, or its purchase offer rejected. At US$15 billion, Iliad would have claimed a 56.6% share in T-Mobile. This will no longer happen, with Iliad dropping its interest in pursuing the deal any further.

Earlier this year, when Sprint had reached the final stages in its acquisition talks with T-Mobile, Iliad announced its offer. When the Sprint deal consecutively fell apart – leading to the stepping down of Dan Hesse, Sprint’s CEO – there were rumors that T-Mobile would be acquired by Iliad. However, those in the know now say that since day one, the Iliad offer was never taken seriously by T-Mobile, as is indicated by the lack of any solid agreement between the two parties. According to a press statement by Iliad, DK and T-Mobile said that they would not take any further bids from Iliad into consideration.

T-Mobile has been showing steady growth over the last one year, with the increasing popularity of its program to buy out the contracts of new subscribers. The intention behind Iliad’s bid was to cut down costs to the tune of nearly US$2 billion if it had successfully gained T-Mobile’s ownership.

Defense Contractor Telephonics to Axe 100 Jobs

Nearly 100 part-time, full-time, and temporary employees of Telephonics Corp, a U.S.-based defense contractor will be facing the axe. The company recently said that it will be cutting at least 100 jobs. Nearly one-third of the employees being made redundant will be via voluntary retirement buyouts, said officials of the company.
About 35 employees, aged 65 years or older, reported took the voluntary retirement packages, informed the CEO and president of the company, Joseph Battaglia. The Farmingdale-headquartered company specializes in the manufacture of telecommunications systems and radar systems.

According to sources, many of the employees being relieved of their jobs were computer professionals. These employees had been hired to oversee the installation of new ERP – a project that was completed earlier in 2014. The other employees that will be losing their jobs are part-time workers as well as temporary ones.

According to Battaglia, the company decided to effect these job cuts in a bid to streamline activities, and get maximum revenue from existing operations. The company, that primarily does business in the defense industry, is apparently affected by the budgetary constraints that have been seen in the Department of Defense in the recent past.

Many of the job cuts were initiated in September 2014. As a result of these measures, the company’s total employee strength now stands at about 1,200. Most of its employees are now located at its Farmingdale headquarters on Long Island, and its Huntington-based manufacturing facilities.

The company also has about 80 employees at its location in Maryland as well as six working in North Carolina.

None of the engineering jobs in the company were affected because of these latest job cuts, the company’s CEO said.

AT&T to Shell Out US$105 million Billing Customers with Authorization

Telecom giant AT&T has agreed to shell out US$105 million towards the settlement of claims about allowing third-party companies to charge its subscribers. These charges to subscribers amount to millions of dollars and the companies billing subscribers were not authorized to do so. The announcement came from state and federal law enforcement officials this week.

According to officials of the Federal Trade Commission and Federal Communications Commission, the telecom major charged its subscribers several millions of dollars as bills from external companies. According to federal officials, subscribers were charged for services such as ringtone subscriptions (typically costing US$9.99 per month), and about 35% of this fee was pocketed by AT&T.

As per the judgment passed by federal and state agency, AT&T will now be required to offer refunds to customers who were billed for the unauthorized charges. The company has been asked to pay US$80 million for such charges. In addition, states that were a part of the settlement will also be paid US$20 million by AT&T towards settlement charges. In addition, the company will shell out settlement charges to the tune of US$ 5 million to the federal government.

According to the truth-in-billing rules laid down by the FCC, telecom companies are required to provide transparency about which services are being charged to consumers. These figures have to feature in the companies’ monthly statements.

According to the chairman of FTC, Edith Ramirez, the settlement of the lawsuit against AT&T reiterates the point that it is unlawful for companies to charge consumers for products or services that they have not authorized. This applies across various formats such as brick-and-mortar stores, mobile shopping as well as online shopping.

Australian Public Sector Logs in to Cloud Services

The Australian government has announced a brand new strategy for cloud computing. As part of this strategy, a large chunk of Australian public sector enterprises will have to upgrade to cloud-based services and software as compared to legacy systems. This strategy will apply for all new ICT-based service refreshes or investments in the ICT domain.

Under the new cloud policy of the government, all agencies must opt for cloud-based services where such services are fit for the purpose in question, offer adequate data protection, and deliver value on investments. This was announced in a joint statement by the Australian Minister for Communications and Minister for Finance this week.

According to the ministers, the Australian Government is aware of the community’s expectations about services that are responsive and efficient. It is also increasingly important for such services to be available through different platforms at any time. The ministers said that the government could appropriately address this need by investing in ICT services – and cloud services are a part of this commitment.

According to the Australian government, access to cloud services can enable public sector enterprises to offer their services more efficiently, improving customer satisfaction and catering to the needs of the community.

With this new cloud policy, the Australian federal government will initiate the process of relocating important cloud data to a secure cloud platform. A new Cloud Services Panel will also be instituted to expedite the selection process of vendors and for easy procurement of services for government agencies.

This new approach is a marked departure from the hitherto conservative approach that the government had to cloud services.

Tata Consultancy Services (TCS), the largest exporter of software from India, is now a part of the U.S.-based organization – the Information Technology Industry Council (ITI). The ITI is an organization of IT services, consulting and business solutions providers. The announcement about this development came this week from TCS.

The 60-member strong organization advocates—for its members—international policies that help its members gain access to new markets, promote innovation and leadership, expand e-commerce activities, and undertake sustainability initiatives. All of these activities are geared towards making its members more competitive on an international level.

In his statement on the development, the president and CEO of ITI, Dean Garfield said that the organization was excited about having TCS on board, especially since the company ranks among the most well-recognized players in the IT marketplace. This also makes TCS the first Indian-headquartered company to join the ranks of its contemporaries in the ITI. According to Garfield, TCS’s addition to the ITI comes at an opportune time, when many companies in the industry are making inroads into the Indian market in a bid to engage more with the consumers there.

According to TCS’s president for North America, Europe and UK, Surya Kant, the company stands committed to enabling companies improve their value offerings to customers. He also added that TCS is keen on helping its customers ‘digitally re-imagine’ their service and business offerings across the world.

Kant said that the success of TCS was largely dependent on a highly skilled workforce as well as competitive, open markets, besides developing an environment that fosters the transformation of business.

Harvard Team Develops Blood and Bacteria Repellent Coating Tech for Medical Devices

Scientists at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed blood and bacteria-repellent coating for medical devices. The team said it had recently received a nod of approval from the U.S. Food and Drug Administration. The coating is being called the Tethered-Liquid-Perfluorocarbon (TLP).

The Institute’s founding director Professor Donald E. Ingber, who is also a senior author of the study, said that a TLP coating will cause unwanted materials to slide off the surface. This technology was inspired by a similar coating that was developed by the study’s co-author Joanna Aizenberg in 2011. The coating technology, which she called Slippery Liquid Infused Porous Surfaces (SLIPS), is capable of repelling most solids and liquids. However, TLP differs in that it has been designed specifically for the medical industry. The technology behind SLIPS was inspired by the carnivorous pitcher plant.

The government offered a grant to Ingber for the research and development of TLP – this also indicates that the government considers this technology to have immense potential.

According to Ingber, the military has also showed an interest in the treatment of blood infection without using a coagulant to cleanse bacteria. Backed by the government funding, the team was expected to show results at the earliest. The research solution was developed over a period of two to three years. The solution, according to the team, works “incredibly” in repelling bacteria.

According to the Wyss Institute’s entrepreneur in residence, Eric Devroe, technologies such as antifouling and anticoagulant have a key role to play in the medical devices industry of the future.
The Harvard team now plans to commercialize TLP.

Global Diabetes Devices Drugs Market Will Experience Accelerating Growth, Reaching Revenues of USD 83.0 Billion in 2019

According to a new market report published by U.S. based market research company, Transparency Market Research “Diabetes Devices and Drugs Market (Devices: Diagnostic & Monitoring and Insulin Delivery Devices, Drugs: Insulin Derivatives, GLP-1 and OADs): Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global diabetes devices and drugs market was valued at USD 54.04 billion in 2012 and is estimated to reach a market worth of USD 83.0 billion in 2019 growing at a CAGR of 5.9% from 2013 to 2019.

Rising prevalence of diabetes is one of the important healthcare concerns on a global level. Insulin is a hormone secreted by pancreas to digest blood sugar. However, in diabetes, it is either not possible for the body to secrete insulin (type-1) or to utilize secreted insulin to metabolize glucose (type-2). The fact (disease conditions), that is, insulin deficiency with the disease is the most important propeller of diabetes devices and drugs market globally. Rising prevalence of diabetes and extensive R&D are the key factors that accentuated the growth of diabetes devices and drugs market. Since no permanent remedy for diabetes has been invented, insulin and drugs therapy, along with proper monitoring and diagnostics have become indispensible part of diabetes patients.

Diabetes devices market is divided into two segments, namely, diabetes diagnostic and monitoring devices and insulin delivery devices. Amongst the diagnostic devices segment, continuous glucose monitoring devices market is expected to grow at a higher growth rate, compared to others. By the end of 2019, test strips market is estimated as the largest in diagnostic and monitoring devices segments. However, market of lancets and analog glucose meters is expected to decline, due to outdated technology. In insulin delivery devices segment, insulin pen is identified as the largest market, followed by syringes. However, by the end of 2019 insulin pumps segment is expected to report highest CAGR.

Diabetes drugs market is segmented as insulin derivatives, oral anti-diabetes drugs and injectable drugs class. Amongst the insulin derivatives segment, long-acting derivatives segment is expected to grow rapidly in the upcoming period. As of 2012, it accounted for the largest market share with 42.77% of the entire market. It is also expected to be the largest segment by the end of 2019. This is followed by rapid-acting insulin market. It is important to highlight that the rest of the segments, such as, premixed, intermediate-acting and short-acting insulin derivatives are expected to decline during the forecast period. While in the oral drugs class segment, the market of SGLT2 inhibitors is expected to grow at an exponential CAGR of 76.8% during forecast period from 2013 to 2019, due to excellent effectiveness in glycemic control and less side-effects. However, traditional drug classes such as sulphonylureas, meglitinides, alpha glucosidase inhibitors and thiazolidinediones are expected to decline during the study period, owing to loss of patents and chronic side-effects. GLP-1 agonists represent injectable drugs class and are also expected to grow at a significant rate during the forecast period. In addition, the report also provides in-depth analysis of pipeline diabetes drugs.

Various products, such as, MK-1293 (Merck & Co., Inc.), LY2605541 (Eli Lilly and Company), IDegLira (Novo Nordisk A/S), Afrezza (MannKind Corporation), Dulaglutide and others are under pipeline studies and expected to enter the market during the forecast period. Hence, on entry of such newer and innovative formulations, the diabetes market is expected to grow steadily during the forecast period.

On the basis of geography, in this report, the diabetes devices and drugs market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). In 2012, the North American region was the largest market in the world, owing to increasing demand of technologically sound devices and sophisticated drugs and rise in diabetic population due to various factors, such as life style and others. However, Asia-Pacific region is assumed as the most promising market during the forecast period from 2013 to 2019. The growth is expected to be driven by factors such as rapidly increasing diabetic population, increased awareness towards self-monitoring and management of diabetes and growing technological penetration in the overall market.

Browse the full Diabetes Devices and Drugs Market report:  

The market is consolidated and highly dominated by selected players operating on a global level. Globally, the market of diabetes devices is dominated by selected number of players, namely; F. Hoffmann La Roche Ltd., LifeScan, Inc. (J&J), Abbott Diabetes Care, and Bayer AG. In addition to this, some other important players that offer an important contribution to the total diabetes devices market include B Braun Melsungen AG and DexCom, Inc. Whereas, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, AstraZeneca plc, Merck, Inc., and Takeda Pharmaceutical Company Limited are the key players having presence in the global diabetes drugs market.

Latest Post

Market Research Reports